Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Huntington Bancshares
HBAN
|
+$233M |
| 2 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$211M |
| 3 |
Amazon
AMZN
|
+$164M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$135M |
| 5 |
Apple
AAPL
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TCF
TCF Financial Corporation Common Stock
TCF
|
+$302M |
| 2 |
CTB
Cooper Tire & Rubber Co.
CTB
|
+$212M |
| 3 |
Ford
F
|
+$181M |
| 4 |
Booking.com
BKNG
|
+$170M |
| 5 |
JPMorgan Chase
JPM
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.39% |
| 2 | Technology | 15.98% |
| 3 | Industrials | 12.96% |
| 4 | Consumer Discretionary | 11.68% |
| 5 | Healthcare | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Sabre
SABR
$704M
| $242K | ﹤0.01% |
19,425
-1,318,381
| -99% | -$18.5M |
|
|
SELF
3302
Global Self Storage
SELF
$57.8M
| $241K | ﹤0.01% |
46,170
| – | – |
|
3303
Pathfinder Bancorp
PBHC
$100M
| $240K | ﹤0.01% |
15,182
+705
| +5% | +$10.6K |
|
3304
Ranger Energy Services
RNGR
$368M
| $239K | ﹤0.01% |
29,858
+24
| +0.1% | +$162 |
|
3305
Neuronetics
STIM
$126M
| $239K | ﹤0.01% |
14,933
-2,409
| -14% | -$33.3K |
|
|
OSH
3306
DELISTED
Oak Street Health, Inc.
OSH
| $237K | ﹤0.01% |
+4,047
| New | +$241K |
|
|
ARD
3307
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $237K | ﹤0.01% |
9,658
+655
| +7% | +$16.9K |
|
3308
NextDecade
NEXT
$1.7B
| $234K | ﹤0.01% |
56,664
+13,629
| +32% | +$38.4K |
|
|
AMTBB
3309
DELISTED
Amerant Bancorp Inc. Class B Common Stock
AMTBB
| $234K | ﹤0.01% |
11,969
+315
| +3% | +$5.32K |
|
3310
Solid Biosciences
SLDB
$777M
| $232K | ﹤0.01% |
4,231
-764
| -15% | -$50.5K |
|
|
STR
3311
DELISTED
Sitio Royalties
STR
| $231K | ﹤0.01% |
+11,381
| New | +$218K |
|
3312
Flexible Solutions
FSI
$63.7M
| $228K | ﹤0.01% |
58,275
-1,623
| -3% | -$5.54K |
|
3313
Relay Therapeutics
RLAY
$4.06B
| $228K | ﹤0.01% |
6,236
| – | – |
|
3314
Q32 Bio
QTTB
$452M
| $228K | ﹤0.01% |
1,741
-2,092
| -55% | -$261K |
|
|
BRFS
3315
DELISTED
BRF SA
BRFS
| $227K | ﹤0.01% |
41,538
| – | – |
|
|
UBX
3316
DELISTED
Unity Biotechnology
UBX
| $227K | ﹤0.01% |
4,900
+34
| +0.7% | +$1.64K |
|
3317
Affinity Bancshares
AFBI
$140M
| $226K | ﹤0.01% |
17,572
-10,769
| -38% | -$135K |
|
3318
SELLAS Life Sciences
SLS
$2.13B
| $226K | ﹤0.01% |
20,320
+4,911
| +32% | +$47.9K |
|
|
ESBK
3319
DELISTED
Elmira Savings Bank Elmira NY
ESBK
| $225K | ﹤0.01% |
15,723
+727
| +5% | +$10.1K |
|
3320
ADMA Biologics
ADMA
$1.97B
| $223K | ﹤0.01% |
139,313
-12,400
| -8% | -$21.8K |
|
3321
Santander
BSBR
$40.7B
| $222K | ﹤0.01% |
28,292
| – | – |
|
|
CELL
3322
DELISTED
PhenomeX Inc. Common Stock
CELL
| $222K | ﹤0.01% |
4,952
| – | – |
|
3323
NovaGold Resources
NG
$2.62B
| $219K | ﹤0.01% |
27,300
| – | – |
|
|
MYND
3324
Mynd.ai
MYND
$17.6M
| $218K | ﹤0.01% |
5,014
+2,627
| +110% | +$90.5K |
|
3325
Genmab
GMAB
$17.7B
| $216K | ﹤0.01% |
+5,282
| New | +$204K |
|
Similar funds
Dimensional Fund Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, Dimensional Fund Advisors held 3,528 positions worth $316B, up 4.5% from $302B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Dimensional Fund Advisors's Q2 2021 filing shows 120 new, 1,436 increased, 1,802 reduced and 67 closed positions. Its largest new stake was Organon & Co: 988,887 shares worth $29.9M. The largest sale was TCF Financial Corporation Common Stock, an estimated $302M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
- Dimensional Fund Advisors's largest Q2 2021 buy was Organon & Co: 988,887 shares worth $29.9M.
- Dimensional Fund Advisors added most to Huntington Bancshares in Q2 2021, an estimated $233M increase.
- Dimensional Fund Advisors's biggest Q2 2021 reduction was Ford, cutting an estimated $181M.
- Dimensional Fund Advisors fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $302M.
- Dimensional Fund Advisors's ten largest holdings make up 10% of its $316B portfolio in Q2 2021.
- Dimensional Fund Advisors opened 120 new positions and closed 67 in Q2 2021.
- Dimensional Fund Advisors's portfolio value rose 4.5% quarter-over-quarter to $316B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.